PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
Specialty oncology diagnostics companies continue to operate in a dynamic healthcare environment, driven by advances in cancer diagnostics, precision medicine and increasing demand for specialized testing services. Against this backdrop, Precipio, Inc. PRPO and NeoGenomics, Inc. NEO are two companies focused on oncology diagnostics through …